Processa Pharmaceuticals Announces Attendance at 2018 ROTH Conference

Friday, March 2, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

HANOVER, Md., March 2, 2018 /PRNewswire/ -- Processa Pharmaceuticals, Inc. ("Processa") (OTC PINK: PCSA), will attend and

participate in meetings at the 30th annual ROTH Conference March 11-14, 2018 at the Ritz Carlton, Laguna Niguel in Orange County, CA.

Patrick Lin, Chief Business and Strategy Officer for Processa, will be available for investor meetings throughout the conference.

About the ROTH Conference

The ROTH Conference, sponsored by ROTH Capital Partners, is an annual gathering of institutional investors, private equity investors, venture capitalists and executives, and service providers, has become a must-attend event for anyone working in the small and mid-cap space.  This year there will be close to 550 participating companies and over 4,700 attendees from the public and private sector.

About PROCESSA

Processa Pharmaceuticals is an emerging clinical stage company focused on the clinical development of drug products that are intended to improve the survival and/or the quality of life of patients who have a high unmet medical need condition.  Within this group of pharmaceutical products, we currently are developing one product for two indications (i.e., the use of a drug to treat a particular disease) and searching for additional products for our portfolio. 

The company has assembled a proven management team, Board of Directors and product development team.  The Processa team has over 25 years of experience developing drug products from IND enabling studies to NDA approvals while working on more than 50 drug development programs, including 30 FDA drug approvals. 

The Company was formed in 2017 and is headquartered in Hanover, Maryland.

Processa's common stock is traded on the OTC PINK SHEET under the symbol PCSA.  For more information, please visit www.processapharma.com.

For More Information:Investor Relations:  Patrick Lin plin@processapharma.com 925-683-3218 Media:  Mark Leonard mark@reachthenextlevel.com 847-651-9682

 

Cision View original content:http://www.prnewswire.com/news-releases/processa-pharmaceuticals-announces-attendance-at-2018-roth-conference-300607227.html

SOURCE Processa Pharmaceuticals



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store